Clinical Trial Update: Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying early administration of tranexamic acid in hip fracture patients with acute blood loss has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fractures

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Henry Ford Health System | Conditions: Hip Fractures, Blood Loss | Phase 3 | Status: WITHDRAWN